United States · FDA National Drug Code directory
Therabreath Plaque Control
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 10237-259_45b3634b-1017-96be-e063-6294a90aaa8c
- Product NDC
- 10237-259
- Form
- RINSE
- Composition / generic term
- CETYLPYRIDINIUM CHLORIDE
- Labeler
- Church & Dwight Co., Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20230425
- Source listing expiry
- 20261231
Source-listed ingredients
- CETYLPYRIDINIUM CHLORIDE — .015 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE, PLASTIC (10237-259-16) · 10237-259-16
- 2 BOTTLE, PLASTIC in 1 BOX (10237-259-26) / 473 mL in 1 BOTTLE, PLASTIC · 10237-259-26
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →